Mohamad Makhzoumi - Net Worth and Insider Trading

Mohamad Makhzoumi Net Worth

The estimated net worth of Mohamad Makhzoumi is at least $1.7 Billion dollars as of 2024-10-18. Mohamad Makhzoumi is the Director of Robinhood Markets Inc and owns about 23,829,279 shares of Robinhood Markets Inc (HOOD) stock worth over $642 Million. Mohamad Makhzoumi is the 10% Owner of Arcellx Inc and owns about 4,745,545 shares of Arcellx Inc (ACLX) stock worth over $455 Million. Mohamad Makhzoumi is also the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $167 Million. Besides these, Mohamad Makhzoumi also holds Savara Inc (SVRA) , MBX Biosciences Inc (MBX) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) . Details can be seen in Mohamad Makhzoumi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mohamad Makhzoumi has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mohamad Makhzoumi

To

Mohamad Makhzoumi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mohamad Makhzoumi owns 33 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Inozyme Pharma Inc (INZY) among others .

Click here to see the complete history of Mohamad Makhzoumi’s form 4 insider trades.

Insider Ownership Summary of Mohamad Makhzoumi

Ticker Comapny Transaction Date Type of Owner
EAR Eargo Inc 2020-10-20 10 percent owner
MTCR Metacrine Inc 2021-12-22 10 percent owner
INZY Inozyme Pharma Inc 2020-07-28 10 percent owner
LIMIT LIMIT 2022-05-25 10 percent owner
LIMIT LIMIT 2020-07-23 10 percent owner
LIMIT LIMIT 2020-07-09 10 percent owner
LIMIT LIMIT 2020-06-30 10 percent owner
LIMIT LIMIT 2020-06-19 10 percent owner
LIMIT LIMIT 2022-04-11 10 percent owner
LIMIT LIMIT 2020-01-29 10 percent owner
LIMIT LIMIT 2020-12-04 10 percent owner
LIMIT LIMIT 2018-06-01 10 percent owner
LIMIT LIMIT 2019-07-22 10 percent owner
LIMIT LIMIT 2019-06-07 10 percent owner
LIMIT LIMIT 2018-12-07 10 percent owner
LIMIT LIMIT 2021-03-16 10 percent owner
LIMIT LIMIT 2018-06-01 10 percent owner
LIMIT LIMIT 2017-11-20 10 percent owner
LIMIT LIMIT 2023-07-17 10 percent owner
LIMIT LIMIT 2018-12-07 10 percent owner
LIMIT LIMIT 2021-04-08 10 percent owner
LIMIT LIMIT 2021-01-01 10 percent owner
LIMIT LIMIT 2021-06-24 director & 10 percent owner
LIMIT LIMIT 2020-12-09 10 percent owner
LIMIT LIMIT 2022-05-03 director & 10 percent owner
LIMIT LIMIT 2022-12-21 10 percent owner
LIMIT LIMIT 2021-07-21 10 percent owner
LIMIT LIMIT 2021-09-30 10 percent owner
LIMIT LIMIT 2021-06-23 10 percent owner
LIMIT LIMIT 2022-06-08 10 percent owner
LIMIT LIMIT 2018-01-19 10 percent owner
LIMIT LIMIT 2021-07-21 10 percent owner
LIMIT LIMIT 2024-04-22 10 percent owner

Mohamad Makhzoumi Latest Holdings Summary

Mohamad Makhzoumi currently owns a total of 15 stocks. Among these stocks, Mohamad Makhzoumi owns 23,829,279 shares of Robinhood Markets Inc (HOOD) as of May 3, 2022, with a value of $642 Million and a weighting of 37.99%. Mohamad Makhzoumi owns 4,745,545 shares of Arcellx Inc (ACLX) as of December 21, 2022, with a value of $455 Million and a weighting of 26.88%. Mohamad Makhzoumi also owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $167 Million and a weighting of 9.88%. The other 12 stocks Savara Inc (SVRA) , MBX Biosciences Inc (MBX) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) have a combined weighting of 25.26% among all his current holdings.

Latest Holdings of Mohamad Makhzoumi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOOD Robinhood Markets Inc 2022-05-03 23,829,279 26.96 642,437,362
ACLX Arcellx Inc 2022-12-21 4,745,545 95.78 454,528,300
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 39.90 167,031,096
SVRA Savara Inc 2023-07-17 24,471,264 3.60 87,974,194
MBX MBX Biosciences Inc 2024-09-16 3,614,486 23.80 86,024,767
KRRO Korro Bio Inc 2024-04-22 1,090,793 76.73 83,696,547
AVEO AVEO Pharmaceuticals Inc 2020-06-19 3,952,958 15.00 59,294,370
AKUS Akouos Inc 2020-06-30 4,294,207 13.29 57,070,011
TRVI Trevi Therapeutics Inc 2022-04-11 11,370,376 3.07 34,907,054
INZY Inozyme Pharma Inc 2020-07-28 2,437,689 5.27 12,846,621
MRKR Marker Therapeutics Inc 2021-03-16 1,071,429 3.33 3,567,859
RGLS Regulus Therapeutics Inc 2020-12-04 645,106 1.58 1,016,042
EAR Eargo Inc 2020-10-20 326,001 2.57 837,823
MTCR Metacrine Inc 2021-12-22 2,563,257 0.00 3,589
GNCAQ Genocea Biosciences Inc 2022-05-25 0 0.00 0

Holding Weightings of Mohamad Makhzoumi


Mohamad Makhzoumi Form 4 Trading Tracker

According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 2 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Robinhood Markets Inc is the sale of 1,952 shares on May 3, 2022, which brought Mohamad Makhzoumi around $19,637.

According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arcellx Inc is the sale of 179 shares on December 21, 2022, which brought Mohamad Makhzoumi around $5,502.

According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 0 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Mohamad Makhzoumi around $7 Million.

More details on Mohamad Makhzoumi's insider transactions can be found in the Insider Trading History of Mohamad Makhzoumi table.

Insider Trading History of Mohamad Makhzoumi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mohamad Makhzoumi Trading Performance

GuruFocus tracks the stock performance after each of Mohamad Makhzoumi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mohamad Makhzoumi is -11.41%. GuruFocus also compares Mohamad Makhzoumi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mohamad Makhzoumi within 3 months outperforms 10 times out of 26 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mohamad Makhzoumi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mohamad Makhzoumi

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 25 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.79 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Mohamad Makhzoumi Ownership Network

Ownership Network List of Mohamad Makhzoumi

No Data

Ownership Network Relation of Mohamad Makhzoumi

Insider Network Chart

Mohamad Makhzoumi Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Mohamad Makhzoumi is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Mohamad Makhzoumi made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Mohamad Makhzoumi Mailing Address

Above is the net worth, insider trading, and ownership report for Mohamad Makhzoumi. You might contact Mohamad Makhzoumi via mailing address: 2855 Sand Hill Road, Menlo Park Ca 94025.

Discussions on Mohamad Makhzoumi

No discussions yet.